Are Dopamine Partial Agonist Antipsychotics Similar? Preclinical Comparison of Aripiprazole, Bifeprunox and Cariprazine

被引：0
|
作者：
Kiss, Bela [1 ]
Gyertyan, Istvan [1 ]
Nemethy, Zsolt [1 ]
Saghy, Katalin [1 ]
Laszy, Judit [1 ]
Fazekas, Karoly [1 ]
Kolok, Sandor [1 ]
Kapui, Zoltan [1 ]
Adham, Nika [2 ]
机构：
[1] Gedeon Richter Plc, Pharmacol & Safety Drug Res, Budapest, Hungary
[2] Forest Res Inst, Jersey City, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2014年 / 75卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
405
引用
收藏
页码：130S / 130S
页数：1
相关论文
共 50 条
  • [1] ARE DOPAMINE PARTIAL AGONIST ANTIPSYCHOTICS SIMILAR? PRECLINICAL COMPARISON OF ARIPIPRAZOLE, BIFEPRUNOX AND CARIPRAZINE
    Kiss, Bela
    Gyertyan, Istvan
    Nemethy, Zsolt
    Saghy, Katalin
    Laszy, Judit
    Fazekas, Karoly
    Kolok, Sandor
    Kapui, Zoltan
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 153 : S94 - S94
  • [2] Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors:: G protein activation and prolactin release
    Cosi, C
    Carilla-Durand, E
    Assié, MB
    Ormiere, AM
    Maraval, M
    Leduc, N
    Newman-Tancredi, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 535 (1-3) : 135 - 144
  • [3] Bifeprunox - A partial dopamine-receptor agonist for the treatment of schizophrenia
    Watanabe, Mark D.
    [J]. FORMULARY, 2007, 42 (06) : 371 - +
  • [4] Cariprazine: A new partial dopamine agonist with a familiar profile
    Hope, Judy
    Keks, Nicholas A.
    [J]. AUSTRALASIAN PSYCHIATRY, 2022, 30 (03) : 382 - 385
  • [5] Effects of Chronic Aripiprazole Administration on Dopamine Receptors: Comparison With Cariprazine
    Adham, Nika
    Choi, Yong Kee
    Kiss, Bela
    Gyertyan, Istvan
    Tarazi, Frank I.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 397S - 397S
  • [6] Effects of Chronic Aripiprazole Administration on Dopamine Receptors: Comparison with Cariprazine
    Tarazi, Frank
    Choi, Yong Kee
    Adham, Nika
    Kiss, Bela
    Gyertyan, Gyertyan
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S138 - S139
  • [7] Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole
    Frankel, Joshua S.
    Schwartz, Thomas L.
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2017, 7 (01) : 29 - 41
  • [8] Aripiprazole:: Pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia
    Gründer, G
    Kungel, M
    Ebrecht, M
    Göröcs, T
    Modell, S
    [J]. PHARMACOPSYCHIATRY, 2006, 39 : S21 - S25
  • [9] Aripiprazole as a dopamine partial agonist - Positive and negative effects
    Glick, ID
    Duggal, V
    Hodulik, C
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (01) : 101 - 103
  • [10] Partial agonists of dopamine receptors: mechanisms and clinical effects of aripiprazole, brexpiprazole and cariprazine
    Cookson, John
    Pimm, Jonathan
    [J]. BJPSYCH ADVANCES, 2023, 29 (02) : 145 - 150
12345